LYNAM PHARMA LIMITED

Active Thame

Other human health activities

4 employees website.com
Life sciences and medical technology Other human health activities
L

LYNAM PHARMA LIMITED

Other human health activities

Founded 1 May 2013 Active Thame, United Kingdom 4 employees website.com
Life sciences and medical technology Other human health activities
Accounts Submitted 30 May 2025 Next due 28 Feb 2026 3 months overdue
Confirmation Submitted 2 Apr 2026 Next due 14 Mar 2027 10 months remaining
Net assets £-275K £125K 2024 year on year
Total assets £140K £64K 2024 year on year
Total Liabilities £415K £189K 2024 year on year
Charges 5
4 outstanding 1 satisfied

Contact & Details

Contact

Registered Address

73 Southern Road Thame Oxon OX9 2ED United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for LYNAM PHARMA LIMITED (08512653), an active life sciences and medical technology company based in Thame, United Kingdom. Incorporated 1 May 2013. Other human health activities. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2014–2024)

Cash in Bank

£98.82k

Increased by £97.85k (+10098%)

Net Assets

-£275.34k

Decreased by £124.55k (-83%)

Total Liabilities

£414.87k

Increased by £188.59k (+83%)

Turnover

N/A

Employees

4

Debt Ratio

297%

Decreased by 3 (-1%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Grants 1

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

3 Allotments 8,939,394 Shares £89.4 Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
23 Jul 20256,666,667£66.67£66.67
23 Jul 2025378,788£3.79£3.79
23 Jul 20251,893,939£18.94£18.94

Officers

Officers

2 active 1 resigned
Status
Langley, Benjamin ThomasDirectorBritishUnited Kingdom4324 May 2024Active
Patel, ShaileshDirectorBritishEngland531 May 2013Active

Shareholders

Shareholders (3)

Laitwood Capital Ltd
100.0%
100
Sinead Mary Patel
0.0%
0

Persons with Significant Control

Persons with Significant Control (3)

3 Active
Active
Notified 24 May 2024
Nature of Control
  • Ownership Of Shares 75 To 100 Percent,voting Rights 75 To 100 Percent,right To Appoint And Remove Directors

Shailesh Patel

British

Active
Notified 6 Apr 2016
Residence England
DOB August 1972
Nature of Control
  • Ownership Of Shares 50 To 75 Percent

Sinead Mary Patel

Irish

Active
Notified 6 Apr 2016
Residence United Kingdom
DOB August 1974
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,voting Rights 25 To 50 Percent

Group Structure

Group Structure

LAITWOOD CAPITAL LTD united kingdom
LYNAM PHARMA LIMITED Current Company

Charges

Charges

4 outstanding 1 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
2 Apr 2026Confirmation StatementConfirmation statement made on 28 Feb 2026 with updates
18 Mar 2026MortgageMortgage Create With Deed With Charge Number Charge Creation Date
11 Feb 2026MortgageMortgage Create With Deed With Charge Number Charge Creation Date
3 Oct 2025CapitalAllotment of shares (GBP 189.39) on 23 Jul 2025
3 Sept 2025CapitalCapital Alter Shares Subdivision
2 Apr 2026 Confirmation Statement

Confirmation statement made on 28 Feb 2026 with updates

18 Mar 2026 Mortgage

Mortgage Create With Deed With Charge Number Charge Creation Date

11 Feb 2026 Mortgage

Mortgage Create With Deed With Charge Number Charge Creation Date

3 Oct 2025 Capital

Allotment of shares (GBP 189.39) on 23 Jul 2025

3 Sept 2025 Capital

Capital Alter Shares Subdivision

Recent Activity

Latest Activity

Confirmation statement made on 28 Feb 2026 with updates

1 months ago on 2 Apr 2026

Mortgage Create With Deed With Charge Number Charge Creation Date

1 months ago on 18 Mar 2026

Mortgage Create With Deed With Charge Number Charge Creation Date

3 months ago on 11 Feb 2026

Allotment of shares (GBP 189.39) on 23 Jul 2025

7 months ago on 3 Oct 2025

Capital Alter Shares Subdivision

8 months ago on 3 Sept 2025